Vera Cappelletti

Dr. Vera Cappelletti

Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 1999 in British Journal of Cancer
Verified
Journal Article
Open access
PMP Miodini
P Miodini
LFL Fioravanti
L Fioravanti
GFG Di Fronzo
G Di Fronzo
VCVera Cappelletti
Vera Cappelletti
We compared the oestrogenic and anti-oestrogenic properties of the two well-known phyto-oestrogens, genistein and quercetin, on the oestrogen-sensitive breast cancer cell line MCF-7. Genistein exerted a biphasic effect on growth of MCF-7 cells, stimulating at low and inhibiting at high concentrations, whereas quercetin was only growth inhibitory. At doses which did not inhibit cell growth, respectively 5 and 1 microM, genistein and quercetin counteracted oestrogen- and transforming growth factor-alpha-promoted cell growth stimulation. Furthermore, genistein promoted transcription of the oestrogen-regulated genes pS2 and cathepsin-D, whereas quercetin interfered with the oestrogen-induced expression of the proteins. In in vitro binding experiments, genistein competed with oestradiol for binding to the oestrogen receptor (ER), but quercetin did not. Quercetin and genistein down-regulated cytoplasmic ER levels and promoted a tighter nuclear association of the ER, but only genistein was able to up-regulate progesterone receptor protein levels. In gel mobility assays, ER preincubation with oestradiol or with the two phyto-oestrogens led to the appearance of the same retarded band, excluding differences between the various complexes in binding to the consensus sequence. The data allowed us to conclude that quercetin acts like a pure anti-oestrogen, whereas genistein displays mixed agonist/antagonist properties, and to formulate a hypothesis on the possible mechanism of action of such phyto-oestrogens.

1 December 2015 in Seminars in Cancer Biology
Verified
Journal Article
Open access
MGMarta Giussani
Marta Giussani
GMGiuseppe Merlino
Giuseppe Merlino
VCVera Cappelletti
Vera Cappelletti
Elda TagliabueElda Tagliabue
Elda Tagliabue
MDMaria Grazia Daidone
Maria Grazia Daidone
Several evidences support the concept that cancer development and progression are not entirely cancer cell-autonomous processes, but may be influenced, and possibly driven, by cross-talk between cancer cells and the surrounding microenvironment in which, besides immune cells, stromal cells and extracellular matrix (ECM) play a major role in regulating distinct biologic processes. Stroma and ECM-related signatures proved to influence breast cancer progression, and to contribute to the identification of tumor phenotypes resistant to cytotoxic and hormonal treatments. The possible clinical implications of the interplay between tumor cells and the microenvironment, with special reference to ECM remodelling, will be discussed in this review.

1 June 2013 in Cell Cycle
Verified
Journal Article
Open access
ABAndrea Bisso
Andrea Bisso
MFMICHELA FALESCHINI
MICHELA FALESCHINI
FZFederico Zampa
Federico Zampa
VCValeria Capaci
Valeria Capaci
JSJacopo De Santa
Jacopo De Santa
GSGiannino Del Sal
Giannino Del Sal
Breast cancer is a heterogeneous tumor type characterized by a complex spectrum of molecular aberrations, resulting in a diverse array of malignant features and clinical outcomes. Deciphering the m...

13 July 2010 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MCMaurizio Callari
Maurizio Callari
VCVera Cappelletti
Vera Cappelletti
LCLoris De cecco
Loris De cecco
VMValeria Musella
Valeria Musella
PMPatrizia Miodini
Patrizia Miodini
MDMaria Grazia Daidone
Maria Grazia Daidone

24 November 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
LCLoris De cecco
Loris De cecco
VMValeria Musella
Valeria Musella
SVSilvia Veneroni
Silvia Veneroni
VCVera Cappelletti
Vera Cappelletti
IBItalia Bongarzone
Italia Bongarzone
MDMaria Grazia Daidone
Maria Grazia Daidone
Gene expression profiling is moving from the research setting to the practical clinical use.

1 August 1998 in Cancer Letters
Verified
Journal Article
Closed access
LFLaura Fioravanti
Laura Fioravanti
VCVera Cappelletti
Vera Cappelletti
PMPatrizia Miodini
Patrizia Miodini
EREnrico Ronchi
Enrico Ronchi
MBMoreno Brivio
Moreno Brivio
GFGiovanni Di Fronzo
Giovanni Di Fronzo